Aerie Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AERI and other ETFs, options, and stocks.

About AERI

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. 

CEO
Rajkumar Kannan
CEORajkumar Kannan
Employees
376
Employees376
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
2005
Founded2005
Employees
376
Employees376

AERI Key Statistics

Market cap
745.83M
Market cap745.83M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.10M
Average volume1.10M
High today
$15.15
High today$15.15
Low today
$15.08
Low today$15.08
Open price
$15.14
Open price$15.14
Volume
994.16K
Volume994.16K
52 Week high
$15.37
52 Week high$15.37
52 Week low
$4.81
52 Week low$4.81

Analyst ratings

88%

of 8 ratings
Buy
12.5%
Hold
87.5%
Sell
0%

AERI Earnings

-$0.79
-$0.16
$0.46
$1.09
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.